This company confuses me. I really have no idea what they are trying to achieve, and looking over all their recent announcements I'm not sure if they know themselves. From the IPO documents it certainly wasn't clear this stock would become a speculative biopharma...
Such a shame the board challengers didn't get the votes.
- Forums
- ASX - By Stock
- ESE
- Ann: Terpenes Formulation Shows Signs of Cellular Growth Arrest
Ann: Terpenes Formulation Shows Signs of Cellular Growth Arrest, page-2
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)